Articles published in Cancer Science & Therapy have been cited by esteemed scholars and scientists all around the world.
Cancer Science & Therapy has got h-index 27, which means every article in Cancer Science & Therapy has got 27 average citations.
Following are the list of articles that have cited the articles published in Cancer Science & Therapy.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
Total published articles |
57 | 46 | 70 | 59 | 42 | 78 | 71 |
Research, Review articles and Editorials |
3 | 4 | 18 | 22 | 27 | 26 | 69 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
41 | 45 | 52 | 37 | 15 | 52 | 2 |
Conference proceedings |
0 | 21 | 45 | 12 | 0 | 162 | 404 |
Citations received as per Google Scholar, other indexing platforms and portals |
4129 | 3358 | 294 | 348 | 345 | 373 | 344 |
| Journal total citations count | 5332 |
| Journal impact factor | 2.06 |
| Journal 5 years impact factor | 2.85 |
| Journal cite score | 6.17 |
| Journal h-index | 27 |
| Journal h-index since 2019 | 18 |
Wang SB, Tao Z, Li P. Lawsone suppresses azoxymethane mediated colon cancer in rats and reduces proliferation of DLD-1 cells via NF-κB pathway. Biomedicine & Pharmacotherapy. 2017 May 1;89:152-61. |
|
Park Y, Son JY, Lee BM, Kim HS, Yoon S. Highly Eribulin-resistant KBV20C Oral Cancer Cells Can Be Sensitized by Co-treatment with the Third-generation P-Glycoprotein Inhibitor, Elacridar, at a Low Dose. Anticancer research. 2017 Aug 1;37(8):4139-46. |
|
å·«ç¿Ÿ, å¤Â忠胜. 结肠癌多è¯è€Âè¯机制的ç â€Ã§Â©Â¶Ã¨Â¿â€ºÃ¥Â±â€¢. 新医å¦. 2015;46(1):1. |
|
Shukla M, Malik MY, Jaiswal S, Sharma A, Tanpula DK, Goyani R, Lal J. A mechanistic investigation of the bioavailability enhancing potential of lysergol, a novel bioenhancer, using curcumin. RSC Advances. 2016;6(64):58933-42. |
|
Tripathi A, Singh DV, Kesharwani RK, Misra K. P-Glycoprotein: A critical comparison of models depicting mechanism of drug efflux and role of modulators. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences. 2015 Jun 1;85(2):359-75. |
|
Salehi B, Zucca P, Sharifiâ€ÂRad M, Pezzani R, Rajabi S, Setzer WN, Varoni EM, Iriti M, Kobarfard F, Sharifiâ€ÂRad J. Phytotherapeutics in cancer invasion and metastasis. Phytotherapy Research. 2018 Apr 19. |
|
Shukla M, Jaiswal S, Sharma A, Srivastava PK, Arya A, Dwivedi AK, Lal J. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. Drug development and industrial pharmacy. 2017 May 4;43(5):847-61. |
|
Sahu BP, Hazarika H, Bharadwaj R, Loying P, Baishya R, Dash S, Das MK. Curcumin-docetaxel co-loaded nanosuspension for enhanced anti-breast cancer activity. Expert opinion on drug delivery. 2016 Aug 2;13(8):1065-74. |
|
Lopes-Rodrigues V, Sousa E, Vasconcelos MH. Curcumin as a modulator of P-glycoprotein in cancer: challenges and perspectives. Pharmaceuticals. 2016 Nov 10;9(4):71. |
|
Miao L, Guo S, Lin CM, Liu Q, Huang L. Nanoformulations for combination or cascade anticancer therapy. Advanced drug delivery reviews. 2017 Jun 1;115:3-22. |
|
Ooko E, Alsalim T, Saeed B, Saeed ME, Kadioglu O, Abbo HS, Titinchi SJ, Efferth T. Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines. Toxicology and applied pharmacology. 2016 Aug 15;305:216-33. |
|
Wu X, Ma J, Ye Y, Lin G. Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb–drug interactions. Journal of Chromatography B. 2016 Jul 15;1026:236-53. |
|
Joshi P, Singh S, Wani A, Sharma S, Jain SK, Singh B, Gupta BD, Satti NK, Koul S, Khan IA, Kumar A. Osthol and curcumin as inhibitors of human Pgp and multidrug efflux pumps of Staphylococcus aureus: reversing the resistance against frontline antibacterial drugs. MedChemComm. 2014;5(10):1540-7. |
|
Adiwidjaja J, McLachlan AJ, Boddy AV. Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions. Expert opinion on drug metabolism & toxicology. 2017 Sep 2;13(9):953-72. |
|
Baek JS, Cho CW. A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells. Oncotarget. 2017 May 2;8(18):30369. |
|
Hu T, Li Z, Gao CY, Cho CH. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World journal of gastroenterology. 2016 Aug 14;22(30):6876. |
|
Chen J, He ZM, Wang FL, Zhang ZS, Liu XZ, Zhai DD, Chen WD. Curcumin and its promise as an anticancer drug: An analysis of its anticancer and antifungal effects in cancer and associated complications from invasive fungal infections. European journal of pharmacology. 2016 Feb 5;772:33-42. |
|
BUNDELA S. DOCTOR OF PHILOSOPHY IN BIOTECHNOLOGY (Doctoral dissertation, RANI DURGAVATI UNIVERSITY). |
|
Bisen PS. Cancer Medicine & Anti Cancer Drugs. studies. 2016;9:14. |
|
張錦新. 利çâ€Â¨Ã¥â€¦Â疫染色得分與臨床病ç†分æžÂåƒ數來探討å²哚胺 2, 3-雙加氧酶 (IDO) 在乳癌的表ç¾. ä¸Â興大å¸çâ€Å¸Ã¥â€˜Â½Ã§Â§â€˜Ã¥Â¸é™¢ç¢©å£«åœ¨è·專çÂÂå¸ä½Âè«–æ–‡. 2014 Jan 1:1-52. |
|
Cancer Science & Therapy received 5332 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 